| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |